Pharma & Biotech
Ceres Power eyes expansion as fuel cell system gains traction
Feedback begins first Bleepa trial with NHS
Imugene presents HER2 immuno-oncology vaccines success at ESMO ahead of 2020 studies
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.